Term Sheets for Startup Founders FAQ for September 2026: Source-Checked Answers to Common Questions

What founders negotiating a 2026 term sheet need to check first: current NVCA forms, post-money SAFE stacking, 1x preference, and the 30-day 83(b) clock.

A term sheet is the short, mostly non-binding document that sets the price, control and downside terms of a venture round before lawyers draft anything. For founders reading it in September 2026, the practical answers come from four sources: the National Venture Capital Association's model documents, Y Combinator's post-money SAFE, Carta's data on how often hard terms actually appear, and the 2025 tax and Delaware law changes that altered what those terms are worth. The short version: economics and control are negotiated separately, most rounds still use plain 1x non-participating preferred, and the forms you copy matter because they are revised roughly once a year. Below are the questions founders ask most, answered from those sources.

Table of Contents

Which forms should a founder actually be working from?

Use the current NVCA model documents, not a set inherited from a prior deal or a friend's data room. The NVCA released 2025 updates to five of its model financing documents in October 2025 — the term sheet, stock purchase agreement, charter, voting agreement and investors' rights agreement — adding mechanics for tranched financings released on milestones or dates, plus language addressing the Outbound Investment Security Program and bulk-data rules. The dated file name tells you what you have: `NVCA-Model-SPA-10-1-2025.docx`. That dating is deliberate.

NVCA's General Counsel Advisory Board revises the models about once a year, so a term sheet pulled from a 2022 round can carry drafting that no longer matches current law or market practice. Re-download before every raise; it costs nothing. The tranched-financing language is the most useful 2025 addition for early-stage founders. If an investor offers half now and half on hitting a milestone, there is now standard drafting for it, which shortens the argument about what counts as achievement and who decides.

SAFE or priced round — what is the real difference?

A SAFE is a convertible instrument, not equity: the investor pays now and receives shares when a priced round happens. Y Combinator's standard is the post-money SAFE, which replaced the original 2013 pre-money version in 2018 and is published free in valuation-cap, discount, MFN and pro-rata-side-letter variants. It grants no board seat, no voting rights and no anti-dilution protection, and pro rata rights only exist if the separate side letter is signed. The word "post-money" is where founders get hurt.

Because the post-money SAFE fixes the investor's percentage of the company *after* conversion, dilution from each new SAFE falls on the founders and earlier SAFE holders rather than being shared across everyone. Stack four or five of them over eighteen months and the cap table at the priced round looks nothing like the spreadsheet you built when you signed the first one. The practical step is mechanical: before signing any new SAFE, model the full conversion with every outstanding SAFE, the new option pool and the priced round together. A SAFE that looks like a 5% sale in isolation is not 5% once three others convert alongside it.

Liquidation preference — what is standard and what is a warning sign

The liquidation preference decides who gets paid first when the company is sold. The founder-relevant baseline is 1x non-participating: the investor takes either their money back or their as-converted share of the proceeds, whichever is larger — not both. Participating preferred is the aggressive version: the investor takes the preference off the top *and then* shares in what is left, which cuts common stock's share at every exit price.

Carta's deal-terms data shows structure remains the exception rather than the rule. Preferences above 1x appeared in roughly 8% of new rounds in Q1 2024, a decade high but still a small minority, while participating preferred climbed from 4.8% of rounds in Q4 2021 to over 15% in early 2023 before falling by more than half again by Q4 2024. What to check in the term sheet: A 2x participating preference is not "just the paper." On a $40M sale with $15M raised on those terms, it can move eight figures from common to preferred before founders see anything.

  • Is the preference 1x, or a multiple?
  • Is it participating or non-participating? If participating, is there a cap?
  • Does it stack by series, or does everyone share pro rata?
  • Do the preference terms apply to an acquisition, or only a formal liquidation?

The 83(b) election and the tax clock nobody can reset

If your founder shares vest, file the Section 83(b) election. The election must be filed no later than 30 days after the stock is transferred, and since April 2025 you can make it on IRS Form 15620 instead of drafting your own written statement. The deadline is unforgiving and relief for a late filing is limited — this is the single most expensive thirty-day window in a founder's life. The reason it matters is the gap between grant and exit.

Filing elects to be taxed on the value at grant, when the stock is worth almost nothing, rather than at each vesting date as the company appreciates. Skip it, and vesting tranches become ordinary income at whatever the shares are worth that month. The qualified small business stock rules changed in the founder's favour in 2025. The One Big Beautiful Bill Act, signed July 4, 2025, expanded §1202 for stock issued after that date: tiered gain exclusions of 50%, 75% and 100% at three, four and five years, a per-issuer cap raised from $10M to $15M, and an issuer gross-asset ceiling raised from $50M to $75M. Stock issued before July 4, 2025 keeps the old five-year holding period and the $10M/$50M limits, so issue date now determines which regime applies to which block of your shares.

Why control terms deserve more attention than they used to

Delaware's SB 21, enacted March 25, 2025, rewrote DGCL §144 to give safe-harbor protection to conflicted transactions involving directors, officers or controlling stockholders when approved by disinterested directors or disinterested stockholders, and shielded controllers from monetary damages for duty-of-care breaches. Most venture-backed startups are Delaware corporations, so this is the law governing your board. The consequence for a founder reading a term sheet is straightforward.

Litigation after the fact is a weaker backstop than it was, which raises the value of the terms that decide governance up front — board composition, what counts as an independent director, and the protective provisions listing decisions that need preferred approval. Read the protective provisions line by line and ask what each one blocks in a bad quarter. A standard list covering new senior securities, sale of the company and changes to the charter is ordinary; one that extends to hiring, annual budgets or any debt above a small threshold hands over operating control under a governance heading.

Frequently Asked Questions

Is a term sheet binding?

Most of it is not, but confidentiality, exclusivity and expense-reimbursement clauses usually are. Read those three closely, because an exclusivity period stops you talking to other investors for its full duration.

Does a SAFE give the investor a board seat?

No. Y Combinator's post-money SAFE grants no board seat, no voting rights and no anti-dilution, and pro rata participation requires signing the separate side letter.

My co-founder's shares vest but mine are fully owned. Do I still file 83(b)?

The election applies to stock subject to a substantial risk of forfeiture. If your shares are not subject to vesting or repurchase, there is nothing to elect on — but confirm against the actual stock purchase agreement, not memory.

Do the new QSBS rules apply to shares I already hold?

No. The expanded tiers and the $15M cap apply to stock issued after July 4, 2025; earlier stock keeps the five-year holding period and the $10M per-issuer cap.


You Might Also Like